Insider · CIK 0001892279
Calabrese Jeffrey
Reports to the SEC for 1 company · DURHAM, NC
Transactions
8
Companies
1
Filings
5
CIK
0001892279
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2022-11-21 | AERIE PHARMACEUTICALS INCStock Option (right to buy)D Disposition to Issuer | −$26.5K |
| 2022-11-21 | AERIE PHARMACEUTICALS INCStock Option (right to buy)D Disposition to Issuer | −$143K |
| 2022-11-21 | AERIE PHARMACEUTICALS INCD Disposition to Issuer | −$283K |
| 2022-11-01 | AERIE PHARMACEUTICALS INCF Tax Payment | −$2,724.38 |
| 2022-08-14 | AERIE PHARMACEUTICALS INCF Tax Payment | −$3,066.05 |
| 2022-07-01 | AERIE PHARMACEUTICALS INCF Tax Payment | −$2,223.76 |
| 2022-07-01 | AERIE PHARMACEUTICALS INCA Award | — |
| 2022-07-01 | AERIE PHARMACEUTICALS INCStock Option (right to buy)A Award | — |
Recent filings
- 4Calabrese Jeffrey0001209191-22-058160SEC(opens sec.gov)
- 4Calabrese Jeffrey0001209191-22-055670SEC(opens sec.gov)
- 4Calabrese Jeffrey0001209191-22-045975SEC(opens sec.gov)
- 4Calabrese Jeffrey0001209191-22-042043SEC(opens sec.gov)
- 4Calabrese Jeffrey0001209191-22-041174SEC(opens sec.gov)
Companies
Address
C/O AERIE PHARMACEUTICALS, INC. 4301 EMPEROR BLVD., SUITE 400
DURHAM, NC, 27703